
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1045 | 1047 | 950 | 919 | 1234 | 1929 |
Fund Return | 4.52% | 4.7% | -5.02% | -2.78% | 4.29% | 6.79% |
Place in category | 386 | 339 | 435 | 385 | 307 | 34 |
% in Category | 88 | 78 | 100 | 99 | 87 | 15 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Europe EUR Z Acc | 4.78B | 6.79 | 6.04 | 9.46 | ||
Europe EUR I Acc | 4.78B | 6.91 | 7.74 | 8.91 | ||
World EUR R Acc | 888.97M | 4.94 | 7.85 | 9.64 | ||
Greater Europe Opportunities EUR I | 459.08M | 6.27 | -3.34 | 8.26 | ||
Greater Europe Opportunities EUR R | 459.08M | 6.18 | -4.30 | 7.18 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Greater Europe Opportunities EUR I | 459.08M | 6.27 | -3.34 | 8.26 | ||
Greater Europe Opportunities EUR R | 459.08M | 6.18 | -4.30 | 7.18 | ||
LINGOHR-EUROPA-SYSTEMATIC-INVEST | 57.58M | 6.16 | 6.86 | 3.67 | ||
Aramea Aktien Select | 42.53M | 10.64 | 7.28 | 3.71 | ||
CHOM CAPITAL Active Return Europe I | 8.74M | 4.87 | 0.42 | 2.43 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
London Stock Exchange | GB00B0SWJX34 | 6.11 | 10,325.0 | -7.36% | |
Adyen | NL0012969182 | 5.81 | 1,233.80 | -2.05% | |
ASML Holding | NL0010273215 | 5.48 | 550.00 | -2.50% | |
Capgemini | FR0000125338 | 4.62 | 120.40 | -6.19% | |
AstraZeneca | GB0009895292 | 4.49 | 10,056.0 | -6.96% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Strong Sell | Sell |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Strong Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review